Table 1.

Demographics of (a) donors, (b) recipients and (c) transplantations

	n	%	No thrombosis		Partial thrombosis		Complete thrombosis		P value*
			n	%	n	%	n	%
(a)
Gender
Male	100	44	69	45	26	44	5	26	0.29
Female	130	56	83	55	33	56	14	74
Cause of death
Stroke	131	57	84	55	32	54	15	79	0.49
Trauma	76	33	53	35	19	32	4	21
Anoxia	15	6.5	10	7	5	9	0	0
Other	8	3.5	5	3	3	5	0	0
	Mean	SD	Mean	SD	Mean	SD	Mean	SD
Age	35	13	34	13	36	13	40	11	0.07
BMI	23	3	23	3	23	2	25	3	0.02
PDRI	1.36	0.44	1.34	0.43	1.4	0.47	1.48	0.40	0.32
(b)
Gender
Male	133	58	92	61	35	59	6	32	0.05
Female	97	42	60	39	24	41	13	68
Previous graft thrombosis	13	6	8	5	4	7	1	5	0.91
Sensitized (PRA>5%)†	19	12	14	14	3	8	2	13	0.66
	Mean	SD	Mean	SD	Mean	SD	Mean	SD
Age	43	8	43	7	43	9	43	5	0.95
BMI	25	4	25	4	25	3	25	3	0.84
(c)
Transplant type
SPK	203	88	137	90	51	86	15	79	0.18
PAK	25	11	14	9	8	14	3	16
PTA	2	1	1	1	0	0	1	5
Donation after circulatory death	21	9	14	9	7	12	0	0	0.30
Retransplant	15	6.5	9	6	4	7	2	11	0.74
Perfusion solution
UW	208	90	139	91	51	86	18	95	0.43
HTK/Other	22	10	13	9	8	14	1	5
Exocrine drainage
Duodenocystostomy	86	37	56	37	22	37	8	42	0.91
Duodeno‐enterostomy	144	63	96	63	37	63	11	58
Anticoagulant therapy
Nadroparin 2850 IE	71	31	43	30	21	36	7	37	0.87
Nadroparin 5700 IE (2dd2850 IE)	143	62	97	66	35	60	11	58
Nadroparin 11400 IE (2dd5700 IE)‡	9	4	6	4	2	2	1	5

^*Chi‐square for categorical variables, anova for continuous variables.

^†PRA known 160/230.

^‡Therapeutic dosage LMWH or iv heparin.